We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Identification of fungal metabolites of anticonvulsant drug carbamazepine.
- Authors
Kang, Su-Il; Kang, Seo-Young; Hur, Hor-Gil
- Abstract
Carbamazepine, which has been used in the treatments of epilepsy, is often found in the environment. Although metabolism of carbamazepine by humans and rats has been characterized, the environmental fate of carbamazepine has not been studied. In this study, two model fungi Cunninghamella elegans ATCC 9245 and Umbelopsis ramanniana R-56, which have previously shown diverse metabolic activities, were tested for metabolism of carbamazepine. Both fungi produced three metabolites each (C1–C3 and M1–M3). All six metabolites showed [M + H]+ at m/ z 253, suggesting addition of one oxygen to the parent compound. High-performance liquid chromatography and liquid chromatography–mass spectrometric analysis detected 10, 11-dihydro-10, 11-epoxycarbamazepine as a major product (C3 (47%) and M3 (85%)) and 3-hydroxycarbamazepine (C2 (15%) and M2 (7%)) from carbamazepine through mixed mono-oxidation reactions in both fungal strains. C. elegans was confirmed to produce 2-hydroxycarbamazepine (C1 (38%)) while U. ramanniana produced a yet unidentified ring-hydroxylated metabolite (M1 (8%)). The current study suggests that carbamazepine is likely to be subjected to initially diverse mono-oxygenation reactions by fungal metabolisms, resulting in the formation of the corresponding metabolites, which were similarly found in mammalian metabolisms.
- Subjects
CARBAMAZEPINE; ANTICONVULSANTS; METABOLITES; DRUGS &; the environment; EFFECT of drugs on fungi; CHROMATOGRAPHIC analysis; BIOLOGICAL products
- Publication
Applied Microbiology & Biotechnology, 2008, Vol 79, Issue 4, p663
- ISSN
0175-7598
- Publication type
Article
- DOI
10.1007/s00253-008-1459-5